Neurostimulation Devices Market by Device Type (Spinal Cord Stimulators, Deep Brain Stimulators, Sacral Nerve Stimulators, Vagus Nerve Stimulators, and Others) Application (Pain Management, Hearing Loss, Urinary Incontinence, Parkinson's Disease, Epilepsy, and Others): Global Opportunity Analysis and Industry Forecast, 20192026
- Published Date: 2020-11-18
- Report ID: 18207
- Pages: 176
-
Format:
The global neurostimulation devices market was valued at $4,387.5 million in 2018 and is projected to reach $11,257.4 million by 2026, registering a CAGR of 12.5% from 2019 to 2026. Neurostimulation is an electrical process of stimulating, inhibiting, modifying, regulating, and altering the activity in the central, autonomous, or peripheral nervous system in the human body. Neurostimulation devices send electrical impulse near to the spine region wherein these signals block the pain signals from reaching the brain. These devices deliver electrical stimulation to the patients brain, spinal cord, and peripheral nervous system. Neurostimulation devices are particularly used for the treatment of neurological disorders such as epilepsy, chronic pain, Parkinsons disease, depression, and other diseases. Advancements in the neurological technologies is delivering relief to the patients affected by psychiatric and neurological disorders.
According to the data published by WHO, there are around 50 million cases of dementia across the globe among which 6070% are Alzheimers and 10 million are added every year. Dementia is the fifth leading cause of death worldwide. Furthermore, the incidence rate for Parkinsons disease is 4.519 per 100,000 population every year.
Rise in prevalence of lifestyle diseases such as depression and chronic pain, increase in number of neurological disorders, and investment for neurological R&D are some of the factors that drive the growth of the global neurostimulation devices market. Moreover, rise in demand for minimal invasive surgery, adoption of technologically advanced products, and surge in aging population also propel the growth of the market as they are more susceptible to neurological disorders, such as Epilepsy, Parkinsons disease, Alzheimers disease, and chronic pain. The major barriers for the growth of the neurostimulation devices market are side effects such as allergic reaction and tingling or prickling of the skin due to implantation of neurostimulation device into the body and increase in device cost. However, the availability of other treatment options such as drug therapies and surgeries restrict the growth of the market.
The neurostimulation devices market is classified on the basis of device type, application, and region. Based on device type, the neurostimulation devices market is divided into spinal cord stimulators, deep brain stimulators, sacral nerve stimulators, vagus nerve stimulators, and others. On the basis of application, the market is classified into pain management, hearing loss, urinary incontinence, Parkinson's disease, epilepsy, and others. Region wise, it is studied across North America, Europe, Asia-Pacific, and LAMEA.
Some of the major players operating in the neurostimulation devices market include Abbott Laboratories, Aleva neurotherapeutics SA, Boston scientific corporation, ElectroCore Inc., EndoStim Inc., Medtronic plc, NeuroPace Inc., Nevro corporation, Neuronetics Inc., NeuroSigma, Inc., and Synapse Biomedical Inc.
KEY BENEFITS FOR STAKEHOLDERS
The study provides an in-depth analysis of the market along with the current trends and future estimations to elucidate the imminent investment pockets.
It offers a quantitative analysis from 2018 to 2026, which is expected to enable the stakeholders to capitalize on prevailing market opportunities.
Comprehensive analysis of all geographical regions is provided to determine the prevailing opportunities.
The key players are profiled, and their strategies are analyzed thoroughly to understand the competitive outlook of the global market.
KEY MARKET SEGMENTS
By Device Type
Spinal Cord Stimulators
Deep Brain Stimulators
Sacral Nerve Stimulators
Vagus Nerve Stimulators
Others
By Application
Spinal Cord Stimulators
Deep Brain Stimulators
Sacral Nerve Stimulators
Vagus Nerve Stimulators
Others
By Region
North America
o U.S.
o Canada
o Mexico
Europe
o Germany
o France
o Spain
o Italy
o UK
o Rest of Europe
Asia-Pacific
o Japan
o India
o China
o Australia
o Rest of Asia-Pacific
LAMEA
o Brazil
o Saudi Arabia
o South Africa
o Rest of LAMEA
LIST OF KEY PLAYERS PROFILED IN THE REPORT
Abbott Laboratories
Aleva neurotherapeutics SA
Boston scientific corporation
ElectroCore Inc.
EndoStim Inc.
Medtronic plc
NeuroPace Inc.
Nevro corporation
Neuronetics Inc.
NeuroSigma, Inc.
Synapse Biomedical Inc.
CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Key benefits for stakeholders
1.3.Key market segments
1.4.Research methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.2.2.Top winning strategies
3.3.Market dynamics
3.3.1.Drivers
3.3.1.1.Rise in prevalence of neurological disorders
3.3.1.2.Increase in investments in R&D for neurological disorders
3.3.2.Restraints
3.3.2.1.Adverse effects and risks associated with neurostimulation devices
3.3.3.Opportunities
3.3.3.1.Use of neurostimulators for new indications
CHAPTER 4:NEUROSTIMULATION DEVICES MARKET, BY DEVICE TYPE
4.1.Overview
4.1.1.Market size and forecast
4.2.Spinal Cord Stimulators
4.2.1.Key market trends, growth factors, and opportunities
4.2.2.Market size and forecast, by region
4.2.3.Market analysis, by country
4.3.Deep Brain Stimulators
4.3.1.Key market trends, growth factors, and opportunities
4.3.2.Market size and forecast, by region
4.3.3.Market analysis, by country
4.4.Sacral Nerve Stimulators
4.4.1.Key market trends, growth factors, and opportunities
4.4.2.Market size and forecast, by region
4.4.3.Market analysis, by country
4.5.Vagus Nerve Stimulators
4.5.1.Key market trends, growth factors, and opportunities
4.5.2.Market size and forecast, by region
4.5.3.Market analysis, by country
4.6.Others
4.6.1.Key market trends, growth factors, and opportunities
4.6.2.Market size and forecast, by region
4.6.3.Market analysis, by country
CHAPTER 5:NEUROSTIMULATION DEVICES MARKET, BY APPLICATION
5.1.Overview
5.1.1.Market size and forecast
5.2.Pain Management
5.2.1.Market size and forecast, by region
5.2.2.Market analysis, by country
5.3.Hearing Loss
5.3.1.Market size and forecast, by region
5.3.2.Market analysis, by country
5.4.Urinary Incontinence
5.4.1.Market size and forecast, by region
5.4.2.Market analysis, by country
5.5.Parkinson's Disease
5.5.1.Market size and forecast, by region
5.5.2.Market analysis, by country
5.6.Epilepsy
5.6.1.Market size and forecast, by region
5.6.2.Market analysis, by country
5.7.Others
5.7.1.Market size and forecast, by region
5.7.2.Market analysis, by country
CHAPTER 6:GLOBAL NEUROSTIMULATION DEVICES MARKET, BY REGION
6.1.Overview
6.1.1.Market size and forecast
6.2.North America
6.2.1.Key market trends and opportunities
6.2.2.Market size and forecast, by device type
6.2.3.Market size and forecast, by application
6.2.4.Market size and forecast, by country
6.2.4.1.U.S. market size and forecast, by device type
6.2.4.2.U.S. market size and forecast, by application
6.2.4.3.Canada market size and forecast, by device type
6.2.4.4.Canada market size and forecast, by application
6.2.4.5.Mexico market size and forecast, by device type
6.2.4.6.Mexico market size and forecast, by application
6.3.Europe
6.3.1.Key market trends and opportunities
6.3.2.Market size and forecast, by device type
6.3.3.Market size and forecast, by application
6.3.4.Market size and forecast, by country
6.3.4.1.Germany market size and forecast, by device type
6.3.4.2.Germany market size and forecast, by application
6.3.4.3.France market size and forecast, by device type
6.3.4.4.France market size and forecast, by application
6.3.4.5.UK market size and forecast, by device type
6.3.4.6.UK market size and forecast, by application
6.3.4.7.Italy market size and forecast, by device type
6.3.4.8.Italy market size and forecast, by application
6.3.4.10.Rest of Europe market size and forecast, by device type
6.3.4.11.Rest of Europe market size and forecast, by application
6.4.Asia-Pacific
6.4.1.Key market trends and opportunities
6.4.2.Market size and forecast, by device type
6.4.3.Market size and forecast, by application
6.4.4.Market size and forecast, by country
6.4.4.1.Japan market size and forecast, by device type
6.4.4.2.Japan market size and forecast, by application
6.4.4.3.China market size and forecast, by device type
6.4.4.4.China market size and forecast, by application
6.4.4.5.India market size and forecast, by device type
6.4.4.6.India market size and forecast, by application
6.4.4.7.Australia market size and forecast, by device type
6.4.4.8.Australia market size and forecast, by application
6.4.4.9.Rest of Asia-Pacific market size and forecast, by device type
6.4.4.10.Rest of Asia-Pacific market size and forecast, by application
6.5.LAMEA
6.5.1.Key market trends and opportunities
6.5.2.Market size and forecast, by device type
6.5.3.Market size and forecast, by application
6.5.4.Market size and forecast, by country
6.5.4.1.Brazil market size and forecast, by device type
6.5.4.2.Brazil market size and forecast, by application
6.5.4.3.Saudi market size and forecast, by device type
6.5.4.4.Saudi market size and forecast, by application
6.5.4.5.South Africa market size and forecast, by device type
6.5.4.6.South Africa market size and forecast, by application
6.5.4.7.Rest of LAMEA market size and forecast, by device type
6.5.4.8.Rest of LAMEA market size and forecast, by application
CHAPTER 7:COMPANY PROFILES
7.1.Abbott Laboratories
7.1.1.Company overview
7.1.2.Company snapshot
7.1.3.Operating business segments
7.1.4.Product portfolio
7.1.5.Business performance
7.1.6.Key strategic moves and developments
7.2.Aleva Neurotherapeutics SA
7.2.1.Company overview
7.2.2.Company snapshot
7.2.3.Operating business segments
7.2.4.Product portfolio
7.2.5.Key strategic moves and developments
7.3.Boston Scientific Corporation
7.3.1.Company overview
7.3.2.Company snapshot
7.3.3.Operating business segments
7.3.4.Product portfolio
7.3.5.Business performance
7.3.6.Key strategic moves and developments
7.4.ElectroCore Inc.
7.4.1.Company overview
7.4.2.Company snapshot
7.4.3.Operating business segments
7.4.4.Product portfolio
7.4.5.Business performance
7.5.EndoStim Inc.
7.5.1.Company overview
7.5.2.Operating business segments
7.5.3.Product portfolio
7.6.Medtronic plc
7.6.1.Company overview
7.6.2.Company snapshot
7.6.3.Operating business segments
7.6.4.Product portfolio
7.6.5.Business performance
Source: Corporate Publications and AMR Analysis
7.7.NeuroPace Inc.
7.7.1.Company overview
7.7.2.Company snapshot
7.7.3.Operating business segments
7.7.4.Product portfolio
7.7.5.Key strategic moves and developments
7.8.Nevro Corporation
7.8.1.Company overview
7.8.2.Operating business segment
7.8.3.Product portfolio
7.8.4.Business performances
7.8.5.Key strategic moves and developments
7.9.Neuronetics Inc.
7.9.1.Company overview
7.9.2.Neuronetics: Company Snapshot
7.9.3.Operating business segments
7.9.4.Product portfolio
7.9.5.Business performance
7.9.6.Key strategic moves and developments
7.10.NeuroSigma Inc.
7.10.1.Company overview
7.10.2.Company snapshot
7.10.3.Operating business segments
7.10.4.Product portfolio
7.10.5.Key strategic moves and developments
7.11.Synapse Biomedical Inc.
7.11.1.Company overview
7.11.2.Company snapshot
7.11.3.Operating business segments
7.11.4.Product portfolio
7.11.5.Key strategic moves and developments
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
